MedImmune LLC acquires Cellective Therapeutics, Inc.

On September 14, 2005, MedImmune LLC acquired Cellective Therapeutics, Inc., a life science company in Maryland, United States, from Alta Partners.

Deal at a glance

AnnouncedSeptember 14, 2005 TypeAdd-on Acquistion TargetCellective Therapeutics, Inc. Buyer MedImmune LLC Seller Alta Partners SectorLife Science LocationMaryland, United States ValueNot disclosed

Target company

Cellective Therapeutics, Inc.

Maryland, United States

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

MedImmune LLC

Company · 6 deals on record

1st transaction in life science
1st transaction in United States

6deals, all time

5in this sector

2013latest

Seller

Alta Partners

Private equity firm · 126 deals on record

126investments

84in this sector

78exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Orbus Therapeutics, Inc.Same sector and country · Oct 2026

ArtesRx LLCSame sector and country · Aug 2026

Firefly Bio, Inc.Same sector and country · Jul 2026

Questions about this deal

Who acquired Cellective Therapeutics, Inc.?MedImmune LLC acquired Cellective Therapeutics, Inc. on September 14, 2005.

Who sold Cellective Therapeutics, Inc.?Alta Partners was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2005.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).